Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wayne M Butler

Showing results (81-90 of 162) with videos related to

Pageof 17
Sort By:
World Journal of Urology|April 26, 2019
Active surveillance outcomes in prostate cancer patients: the use of transperineal template-guided mapping biopsy for patient selectionGregory S Merrick, Ava Tennant, Ryan Fiano, et al.
Brachytherapy|March 12, 2013
Impact of small prostate size on postimplant prostate dosimetry: analysis of a large community databaseAl V Taira, Gregory S Merrick, Peter Grimm, et al.
American Journal of Clinical Oncology|June 6, 2021
The Impact of Body Mass Index on Freedom From Therapeutic Intervention and Quality of Life in Active Surveillance Prostate Cancer PatientsGregory S Merrick, Robert Galbreath, Ryan Fiano, et al.
Brachytherapy|December 31, 2010
The correlation between annular treatment margins and biochemical failure in prostate brachytherapy patients with optimized intraprostatic dosimetryNathan Bittner, Gregory S Merrick, Wayne M Butler, et al.
Brachytherapy|April 6, 2004
Prostate-specific antigen (PSA) velocity and benign prostate hypertrophy predict for PSA spikes following prostate brachytherapyGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
BJUI Compass|April 27, 2022
The impact of age on prostate cancer progression and quality of life in active surveillance patientsGregory S Merrick, Gabe Rohmann, Robert Galbreath, et al.
Brachytherapy|March 23, 2012
Long-term outcome for very high-risk prostate cancer treated primarily with a triple modality approach to include permanent interstitial brachytherapyNathan Bittner, Gregory S Merrick, Wayne M Butler, et al.
BJU International|March 6, 2010
Relationship between prostate cancer mortality and number of unfavourable risk factors in men treated with definitive brachytherapyAl V Taira, Gregory S Merrick, Robert W Galbreath, et al.
BJU International|December 13, 2005
Severity categories of the International Prostate Symptom Score before, and urinary morbidity after, permanent prostate brachytherapySarah Gutman, Gregory S Merrick, Wayne M Butler, et al.
BJU International|August 17, 2010
Prostate cancer death is unlikely in high-risk patients following quality permanent interstitial brachytherapyGregory S Merrick, Wayne M Butler, Robert W Galbreath, et al.
Pageof 17

Showing results (81-90 of 162) with videos related to

Sort By:
Pageof 17
World Journal of Urology|April 26, 2019
Active surveillance outcomes in prostate cancer patients: the use of transperineal template-guided mapping biopsy for patient selectionGregory S Merrick, Ava Tennant, Ryan Fiano, et al.
Brachytherapy|March 12, 2013
Impact of small prostate size on postimplant prostate dosimetry: analysis of a large community databaseAl V Taira, Gregory S Merrick, Peter Grimm, et al.
American Journal of Clinical Oncology|June 6, 2021
The Impact of Body Mass Index on Freedom From Therapeutic Intervention and Quality of Life in Active Surveillance Prostate Cancer PatientsGregory S Merrick, Robert Galbreath, Ryan Fiano, et al.
Brachytherapy|December 31, 2010
The correlation between annular treatment margins and biochemical failure in prostate brachytherapy patients with optimized intraprostatic dosimetryNathan Bittner, Gregory S Merrick, Wayne M Butler, et al.
Brachytherapy|April 6, 2004
Prostate-specific antigen (PSA) velocity and benign prostate hypertrophy predict for PSA spikes following prostate brachytherapyGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
BJUI Compass|April 27, 2022
The impact of age on prostate cancer progression and quality of life in active surveillance patientsGregory S Merrick, Gabe Rohmann, Robert Galbreath, et al.
Brachytherapy|March 23, 2012
Long-term outcome for very high-risk prostate cancer treated primarily with a triple modality approach to include permanent interstitial brachytherapyNathan Bittner, Gregory S Merrick, Wayne M Butler, et al.
BJU International|March 6, 2010
Relationship between prostate cancer mortality and number of unfavourable risk factors in men treated with definitive brachytherapyAl V Taira, Gregory S Merrick, Robert W Galbreath, et al.
BJU International|December 13, 2005
Severity categories of the International Prostate Symptom Score before, and urinary morbidity after, permanent prostate brachytherapySarah Gutman, Gregory S Merrick, Wayne M Butler, et al.
BJU International|August 17, 2010
Prostate cancer death is unlikely in high-risk patients following quality permanent interstitial brachytherapyGregory S Merrick, Wayne M Butler, Robert W Galbreath, et al.
Pageof 17